Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

NCT05316129 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Follicle Stimulating Hormone Receptor T Cells

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]